About this trial
A phonophoresis-based drug delivery system is a synchronous approach to improve local drug penetration in neuromuscular diseases associated with neuronal damage, excruciating pain, and local inflammation. Chitosan, a semi-synthetic material, is obtained by partial deacetylation of chitin amines, resulting in copolymers of N-acetylglucosamine and N-glucosamine. Its use has been explored in various biomaterial and medical applications. Chitosan has emerged as a cost-effective, biocompatible, and biodegradable material with many desirable biological properties, improvement of homeostasis and antiviral potential. Chitosan was found to suppress pro-inflammatory cytokines and decreased peripheral nerve edema, the polycationic nature of chitosan allows it to absorb protons, which reduces inflammation and provides an analgesic effect.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Their age will be ranged from 16-18 years
body mass index will be 26.58 kg/m2.
used a smart phone for more than 1 year for at least 2 hours per day
complaining of neck pain after using a smart phone, addiction to smart phone in accordance with the smart phone addiction scale (SAS)
Disqualifiers
any previous head and neck injuries or surgeries
any congenital abnormalities or symptomatic deformity in either the cervical or the lumbar spine
any uncorrected visual or auditory problems, dizziness, vertigo and headache
any systematic diseases, any addiction to alcohol, any additive drugs and sedatives within 48 hours previous to tests
Trial design
Parallel
Treatments tested in this trial
Chitosan Phonophresis
DrugChitosan Phonophresis, three times per week for four weeks.
selected physical therapy exercise
Other interventionselected neck exercise and electrotherapy on cervical region
Treatment groups
Trial outcomes
Primary outcomes
Smartphone Addiction Scale-Short Version (SAS-SV)
SAS-SV was psychometrically robust in measuring the severity of smartphone addiction
The visual analogue scale
was utilized to evaluate pre- and post-treatment neck pain
Neck disability index
assess how neck pain and other symptoms manifested during various functional activities. Ndi had been reported as a reliable (Cronbach's alpha: 0.89) and valid instrument to evaluate self-rated disability in patients with neck pain
Secondary outcomes
Cervical ROM
Cervical active ROM will be measured for each participant in the study by digital goniometer device.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.